Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_assertion type Assertion NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_head.
- NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_assertion description "[Although the CCR2 V64I genotype showed no association with nephropathy, the frequency of the CCR5 59029 A-positive genotype (G/A or A/A) was significantly higher in patients with microalbuminuria (urinary albumin-to-creatinine ratio [ACR] > or = 30 and <300 mg/gCre, 86%) and patients with macroalbuminuria (ACR > or = 300 mg/gCre, 87%) than in patients with normoalbuminuria (ACR <30 mg/gCre, 75%; P = 0.0095).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_provenance.
- NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_assertion evidence source_evidence_literature NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_provenance.
- NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_assertion SIO_000772 11756347 NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_provenance.
- NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_assertion wasDerivedFrom befree-20150227 NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_provenance.
- NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_assertion wasGeneratedBy ECO_0000203 NP1010774.RAsa8xnl_pZ0cVNul0VPP4iK5aZvlgzNa3PR5QEi5sgNY130_provenance.